A new, three-year NIH grant will expand Dr. Elizabeth Yen's research and initial pilot study findings about the effects of prenatal opioid exposure in an infant's first year of life.
Targeted genome sequencing found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic techniques remains a barrier to diagnosis and medical care for genetic disorders in the first year of life.
Tufts Clinical and Translational Science Institute (CTSI) has received a $78.4 million Clinical and Translational Science Award from the NIH, the fourth consecutive grant since its founding in 2008.
Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.
Researchers from the Division of Endocrinology at Tufts Medical Center found that vitamin D was effective in lowering the risk for developing diabetes in adults with prediabetes.